| B. Oncotype | |||
|---|---|---|---|
| Number n (%) |
PCNSL | GBM | METs |
| 77 (42.8%) | 45 (25.0%) | 58 (32.2%) | |
| Mean age y (± SD) | 61.2 ± 8.0 | 62.1 ± 10.7 | 57.7 ± 7.6 |
| Ratio M/F | 1.57 | 1.65 | 0.87 |
PCNSLs, Primary central nervous system lymphomas; GBMs, Glioblastomas; METs, Metastases.
| B. Oncotype | |||
|---|---|---|---|
| Number n (%) |
PCNSL | GBM | METs |
| 77 (42.8%) | 45 (25.0%) | 58 (32.2%) | |
| Mean age y (± SD) | 61.2 ± 8.0 | 62.1 ± 10.7 | 57.7 ± 7.6 |
| Ratio M/F | 1.57 | 1.65 | 0.87 |
PCNSLs, Primary central nervous system lymphomas; GBMs, Glioblastomas; METs, Metastases.